Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study | British Journal of Cancer
Treatment Options in Hepatitis C (09.01.2017)
Sofosbuvir - Wikipedia
Advances in Treatment of Hepatitis C | IntechOpen
Screen Shot 2017-01-01 at 8.20.43 PM.png
Therapieerfolge nach Interferon-Therapie - 12 - 2014 - Heftarchiv - AMT
The ProTide Prodrug Technology: From the Concept to the Clinic | Journal of Medicinal Chemistry
Sofosbuvir
Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Cav channels - ScienceDirect
Sofosbuvir - Wikipedia
Sofosbuvir (Sovaldi) | Basicmedical Key
Infectious Block 4 PHAR 7321 Flashcards | Quizlet
Sofosbuvir - an overview | ScienceDirect Topics
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
Cardiovascular Risk Management and Hepatitis C: Combining Drugs | SpringerLink
Sofosbuvir and daclatasvir - Hessel - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
Sofosbuvir Sovaldi - Treatment - Hepatitis C Online
What is the mechanism of action of sofosbuvir in the body? - Quora
Sofosbuvir (Sovaldi) | Basicmedical Key
Mechanism of action of therapy and therapeutic targets for... | Download Scientific Diagram
Hepatitis C virus and the kidney | Nature Reviews Nephrology
Viruses | Free Full-Text | Hepatitis C Virus and Natural Compounds: A New Antiviral Approach?
Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity” - American Journal of Transplantation
Advances in hepatitis B therapeutics - Vicente Soriano, Pablo Barreiro, Edward Cachay, Shyamasundaran Kottilil, José V. Fernandez-Montero, Carmen de Mendoza, 2020
Hepatitis C Virus
